Liver Cirrhosis Research Today is a free monthly online journal that collates and summarizes the latest research about Liver Cirrhosis, including details on alcohol, treatment, drugs, effects, causes.

Volume 4 (2007), Issue 9 (September)

1. A case of persistent anemia and alcohol abuse.
   Nat Clin Pract Gastroenterol Hepatol, 4(9): 521-6. [Abstract] [Full-text]
2. Grey scale enhancement by a new self-made contrast agent in early cirrhotic stage of rabbit liver.
   BMC Gastroenterol, 7: 32. [Abstract] [Full-text]
3. Superparamagnetic iron oxides and low molecular weight gadolinium chelates are synergistic for direct visualization of advanced liver fibrosis.
   J Magn Reson Imaging, 26(3): 728-37. [Abstract] [Full-text]
4. Gene expression profile analysis of the spontaneous reversal of rat hepatic fibrosis by cDNA microarray.
   Dig Dis Sci, 52(10): 2591-600. [Abstract] [Full-text]
5. Quercetin prevents oxidative stress in cirrhotic rats.
   Dig Dis Sci, 52(10): 2616-21. [Abstract] [Full-text]
6. Diagnosis and measurement of liver fibrosis by MRI in bile duct ligated rats.
   Dig Dis Sci, 52(10): 2601-9. [Abstract] [Full-text]
7. The serum endothelin-1 level in steatosis and NASH, and its relation with severity of liver fibrosis.
   Dig Dis Sci, 52(10): 2622-8. [Abstract] [Full-text]
8. Positive CAGE screen correlates with cirrhosis in veterans with chronic hepatitis C.
   Dig Dis Sci, 52(10): 2564-9. [Abstract] [Full-text]
9. Orlistat reverse fatty infiltration and improves hepatic fibrosis in obese patients with nonalcoholic steatohepatitis (NASH).
   Dig Dis Sci, 52(10): 2512-9. [Abstract] [Full-text]
10. Effects of hepatitis C-induced liver fibrosis on survival in kidney transplant candidates.
    Dig Dis Sci, 52(10): 2501-7. [Abstract] [Full-text]
11. Selective inactivation of NF-kappaB in the liver using NF-kappaB decoy suppresses CCl4-induced liver injury and fibrosis.
    Am J Physiol Gastrointest Liver Physiol, 293(3): G631-9. [Abstract] [Full-text]
12. The use of transient elastometry for assessing liver fibrosis in patients with HIV and hepatitis C virus coinfection.
    Clin Infect Dis, 45(8): 969-74. [Abstract] [Full-text]
13. Diffusion-weighted MRI for quantification of liver fibrosis: preliminary experience.
    AJR Am J Roentgenol, 189(4): 799-806. [Abstract] [Full-text]
14. Role of MDCT in the diagnosis of hepatocellular carcinoma in patients with cirrhosis undergoing orthotopic liver transplantation.
    AJR Am J Roentgenol, 189(4): 792-8. [Abstract] [Full-text]
15. Novel serum biomarker candidates for liver fibrosis in hepatitis C patients.
    Clin Chem, 53(10): 1792-9. [Abstract] [Full-text]
16. Thioacetamide-induced cirrhosis in selenium-adequate mice displays rapid and persistent abnormity of hepatic selenoenzymes which are mute to selenium supplementation.
    Toxicol Appl Pharmacol, 224(1): 81-8. [Abstract] [Full-text]
17. The relationship between iron overload and clinical characteristics in a Spanish cohort of 100 C282Y homozygous hemochromatosis patients.
    Ann Hematol, 86(11): 831-5. [Abstract] [Full-text]

© 2004-2010 Liver Cirrhosis Research Today. All Rights Reserved.